Keyphrases
Steatohepatitis
100%
Telmisartan
100%
Adipose Tissue
100%
Macrophage Infiltration
100%
Hepatic Macrophages
100%
Nonalcoholic Steatohepatitis
27%
CCR2
27%
Liver
18%
High-fat Diet
18%
MRNA Expression
18%
Metabolic Syndrome
18%
Methionine
18%
Choline-deficient
18%
Serum Adiponectin
18%
Adipocyte
9%
Therapeutic Strategies
9%
C57BL
9%
Therapeutic Tool
9%
Macrophages
9%
Infiltration
9%
Monocyte Chemoattractant protein-1 (MCP-1)
9%
New Therapeutic Strategies
9%
Non-alcoholic Fatty Liver Disease (NAFLD)
9%
Transforming Growth Factor-β
9%
Fibrogenesis
9%
Hepatic Fat
9%
Type I Collagen
9%
Low-density Lipoprotein
9%
Liver Steatosis
9%
Angiotensin II Type 1 Receptor Blocker
9%
Hepatic Manifestations
9%
Adipocyte Size
9%
Visceral Fat Tissue
9%
Medicine and Dentistry
Steatohepatitis
100%
Macrophage
100%
Adipose Tissue
100%
Telmisartan
100%
Nonalcoholic Fatty Liver
36%
Adipocyte
18%
Metabolic Syndrome
18%
Adiponectin
18%
Choline
18%
Methionine
18%
Messenger RNA
18%
High Fat Food
18%
Fatty Liver
9%
Triacylglycerol
9%
Collagen Type 1
9%
In Vitro
9%
Receptor
9%
Fibrinogen
9%
Monocyte Chemotactic Protein 1
9%
Visceral Fat
9%
Fibrogenesis
9%
C57BL/6
9%
Chemokine Receptor
9%
Beta Chemokine
9%
Low-Density Lipoprotein
9%
Angiotensin 1 Receptor Antagonist
9%
Cancer Growth Factor
9%
Pharmacology, Toxicology and Pharmaceutical Science
Telmisartan
100%
Nonalcoholic Fatty Liver
36%
Metabolic Syndrome X
18%
Methionine
18%
Choline
18%
Adiponectin
18%
Messenger RNA
18%
Murine
9%
Fatty Liver
9%
Triacylglycerol
9%
Collagen Type 1
9%
Receptor
9%
Monocyte Chemotactic Protein 1
9%
Fibrinogen
9%
C57BL 6 Mouse
9%
Low Density Lipoprotein
9%
Chemokine Receptor
9%
Angiotensin 1 Receptor Antagonist
9%
Beta Chemokine
9%
Cancer Growth Factor
9%